格隆汇12月31日丨德斯控股(08437.HK)公告，于2025年12月31日，公司(作为卖方)与买方Yan Xianchang 订立买卖协议，据此，卖方同意出售而买方同意购买目标公司德斯(香港)控股的全部已发行股本，代价 为1港元。 目标公司为一间于香港注册成立有限公司，并为公司直接全资附属公司。其主要从事提供医疗美容服务 及护肤品销售。 董事会认为，出售事项将不会对集团整体的财务状况及营运造成任何重大不利影响。出售事项将使集团 能够(i)藉减少负债及降低资产负债率，提升其财务状况；(ii)精简业务营运；及(iii)重新分配现有资源以 重点发展其核心业务。董事会认为出售事项的条款为正常商业条款，属公平合理且符合公司及其股东的 整体利益。 完成后，目标公司将不再为公司附属公司，而公司亦将不再持有目标公司任何已发行股本。因此，目标 公司的财务业绩将不再综合并入集团的综合财务报表。 ...

智通财经APP讯，中建富通(00138)发布公告，于2025年12月31日，该等卖方(East Advance Holdings Limited(作为卖方A)及 Blackbird Automotive Holding Limited(作为卖方B)各为公司全资附属公司)与买方 Entex International Holding Limited 订立买卖协议。 据此，该等卖方同意出售而买方同意购买待售股份(占目标公司 Blackbird Works Supply Co. Limited 95% 已发行股本)，代价为1710万港元。买卖协议为无条件及完成已于2025年12月31日落实。 紧接出售事项前，目标公司分别由卖方A拥有99.999%及由卖方B拥有0.001%。目标公司主要于香港提 供汽车拖运及物流服务。完成后，目标公司由买方拥有95%及由卖方A拥有5%。 董事认为，出售事项对集团有利，乃由于其能简化集团的组织结构及精简业务运营;改善集团的营运资 金状况;及免除目标公司未来业务发展所需的额外现金流注资要求。 ...

面对业绩下行与股东压力，百事公司已与激进投资机构埃利奥特（Elliott Investment Management）达成战略改革协议，旨在通过业务精简、成本 重组与产品线聚焦应对当前增长困境。 根据12月9日公布的方案，百事将在2026年前实施以下结构性调整：削减美国市场近20%的产品线（SKU）、关闭三家工厂并推动裁员与产线优 化、将资源转向平价产品与健康化创新。该计划直接回应了埃利奥特此前对其"品牌臃肿、市场份额流失"的批评。 此次合作源于埃利奥特于2024年建立的约40亿美元百事股份持仓。在百事股价较2023年高点下跌约25%、同时面临碳酸饮料与零食双线竞争压力 的背景下，该协议被视为管理层主动推进改革、以规避潜在代理权争夺的防御性举措。公司同步更新业绩指引，预计2026财年有机收入增长 2%-4%，并通过供应链与运营优化，目标在三年内推动核心营业利润率提升至少100个基点。 根据协议，百事公司将围绕产品、成本与营销展开系统性改革。产品端将实施"平价化"与"健康化"双轨策略：一方面扩大全渠道低价日常产品供 给，另一方面计划于2026年推出以高蛋白、全谷物、零添加为特点的"清洁标签"创新系列，包括Sim ...

Core Viewpoint -耀星科技集团 plans to sell its entire issued share capital of Anxu Technology Co., Ltd. to Syno Strategy Ltd for a total consideration of HKD 110 million, aiming to streamline operations and focus on its core visual display solutions business [1] Group 1: Company Strategy - The sale is part of a strategic decision to terminate non-core businesses in China, specifically in IT consulting and hotel booking and event planning services [1] - The board believes that this move will help reduce losses and reallocate management and financial resources to strengthen and expand the core business [1] Group 2: Financial Details - The total consideration for the sale is HKD 110 million [1]

Core Viewpoint - The company,耀星科技集团, plans to sell its entire issued share capital of 安绪科技有限公司 to Syno Strategy Ltd for a total consideration of HKD 110 million, aiming to streamline operations and focus on its core visual display solutions business [1] Group 1: Business Strategy - The sale is part of a strategic decision to terminate non-core businesses in China, specifically in IT consulting and hotel booking and event planning services [1] - The board believes that this move will help reduce losses and reallocate management and financial resources to strengthen and expand the core business [1]

Group 1 - Fosun Pharmaceutical (001288) announced the sale of its wholly-owned subsidiary, Henan Fosun Smart Energy Technology Co., Ltd., for 73 million yuan to Henan Xisheng Industrial Development Co., Ltd. [1] - The buyer, Henan Xisheng, is jointly controlled by Nanyang Industrial Investment Group (51% stake) and the Xichuan Finance Bureau (49% stake), focusing on property leasing, equipment leasing, and overseas engineering contracting [3]. - The subsidiary, Fosun Smart Energy, primarily operates photovoltaic power generation systems, with three installed capacities of approximately 6.09 MW, 6.38 MW, and 14.89 MW [3]. Group 2 - Fosun Pharmaceutical stated that its core business is pharmaceutical manufacturing and sales, and the photovoltaic business was initially intended to support internal power needs and generate external revenue, but it is not a core focus of the group [3]. - The sale aligns with the company's long-term strategy to streamline operations and focus on key business areas, and it will not significantly impact the company's daily pharmaceutical production and operations [3].

Core Viewpoint - The company is engaging in significant asset sales to improve liquidity and focus on core business operations, which is expected to enhance financial stability and operational efficiency [1][2][3] Group 1: Asset Sales - The company announced the conditional sale of an 18.06% stake in its joint venture, Science City Financing Leasing, for RMB 417 million [1] - Additionally, the company plans to sell all shares of Hengcheng for RMB 11.3386 million, with the completion of this sale contingent upon Hengcheng undergoing a restructuring process [1][2] Group 2: Financial Impact - The restructuring of Hengcheng will involve transferring non-core assets and liabilities, resulting in a net restructuring obligation of approximately RMB 122 million as of June 30, 2025 [2] - The company reported a current liability exceeding current assets by approximately RMB 699 million as of December 31, 2024, with cash and cash equivalents around RMB 20 million [3] - Proceeds from the asset sales are expected to be used to repay shareholder loans, improving the company's net debt situation and reducing interest payments, thereby enhancing profitability [3] Group 3: Strategic Focus - The asset sales are part of a strategy to streamline operations and optimize resource allocation, allowing the company to concentrate on its core business [2] - The board believes that focusing resources on core operations will improve profitability and strengthen the long-term outlook of the business [3]

Core Viewpoint - The company is engaging in significant asset sales to improve liquidity and focus on core business operations, which is expected to enhance financial stability and operational efficiency [1][2][3] Group 1: Asset Sales - The company has agreed to sell an 18.06% stake in its joint venture, Science City Financing Leasing, for RMB 417 million [1] - Additionally, the company will sell all shares of Heng Cheng for RMB 11.34 million, with Heng Cheng undergoing a restructuring process prior to the sale [1][2] Group 2: Financial Impact - The restructuring of Heng Cheng will involve transferring non-core assets and liabilities, resulting in a net restructuring obligation of approximately RMB 122 million as of June 30, 2025 [2] - The company reported a current liability exceeding current assets by approximately RMB 699 million as of December 31, 2024, with cash and cash equivalents around RMB 20 million [3] - Proceeds from the asset sales will be used to repay shareholder loans, improving the company's net debt situation and reducing interest payments, thereby enhancing profitability [3] Group 3: Strategic Focus - The asset sales are part of a strategy to streamline operations and optimize resource allocation, allowing the company to concentrate on its core business [2][3] - The board believes that focusing on core operations will improve profitability and strengthen the long-term outlook of the business [3]

Group 1 - Dongwu Cement (00695) has seen a decline of over 15%, reaching a low of 4.63 HKD, which is nearly a 30% drop from the high of 6.52 HKD on Monday [1] - As of the latest update, the stock is down 12.57%, trading at 4.8 HKD with a transaction volume of 13.48 million HKD [1] Group 2 - The controlling shareholder Goldview is selling approximately 155 million shares to Suzhou State-owned Assets Supervision and Administration Commission's wholly-owned subsidiary, Hong Kong Port and Shipping, for about 286 million RMB [1] - Goldview is also selling 49.68 million shares to Fen Yuan Capital for 91.8 million RMB [1] - After these transactions, Hong Kong Port and Shipping will become the largest single shareholder of the company with a 28% stake, while Fen Yuan Capital will hold 9% [1] - Goldview's stake in the company will decrease from 53.89% to 16.89%, resulting in it no longer being the controlling shareholder [1] Group 3 - Dongwu Cement plans to sell all shares of Dongfang Chengzheng Rare Earth for 10 million HKD [1] - The company believes that selling the rare earth business will allow it to concentrate financial resources on its cement operations, improving cash flow and financial flexibility [1] - This strategic move aims to streamline operations and enhance overall financial performance [1]

Core Viewpoint - Intel has revised its adjusted operating expense target for 2025 from $17 billion to $16.8 billion, primarily due to the exclusion of its programmable chip business Altera from consolidated financial statements [1] Group 1: Financial Adjustments - The sale of 51% of Altera to Silver Lake Partners was completed in April, with the transaction valuing Altera at $8.75 billion, significantly lower than Intel's acquisition price of nearly $17 billion in 2015 [1] - Altera generated revenue of $816 million in the first half of 2025, with a gross margin of 55% and operating expenses of $356 million during the same period [1] - Intel's target for total operating expenses for 2026 remains unchanged at $16 billion [1] Group 2: Strategic Moves - Under CEO Lip-Bu Tan's leadership, Intel is streamlining operations to enhance cash reserves, which includes multiple rounds of adjustments and management changes this year [1] - The U.S. government acquired a 10% stake in Intel by converting subsidies into equity, indicating a strategic partnership [1]